HSD17B2 and colorectal carcinoma: Supporting our findings, TCGA COAD analysis and others (25) have shown that HSD17B2 expression is downregulated in CRC; however, our data indicated no change in HSD17Β2 protein expression, suggesting this pathway might remain active.